Synthokem Labs specializes in producing APIs and intermediates for the global pharma industry.
01 1Synthokem Labs Private Limited
02 4Granules India Limited
03 1Chunghwa Chemical Synthesis & Biotech. Ltd
04 1AX Pharmaceutical Corp
05 1Fagron Inc
06 1Kalchem International inc
07 1LETCO MEDICAL, LLC
08 1Medisca Inc.
09 1Professional Compounding Centers of America dba PCCA
10 2Seven Star Pharmaceutical Co., Ltd.
11 1Spectrum Laboratory Products, Inc.
12 1Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
13 1Zhejiang Haizhou Pharmaceutical Co., Ltd.
01 4METHOCARBAMOL
02 10Methocarbamol
03 1Methocarbamol DC90
04 1Methocarbamol Granules DC 90%
05 1Methocarbomal Granules DC 90%
01 1Canada
02 2China
03 5India
04 1Netherlands
05 3Taiwan
06 4U.S.A
07 1United Kingdom
Synthokem Labs specializes in producing APIs and intermediates for the global pharma industry.
NDC Package Code : 58343-0138
Start Marketing Date : 1983-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-022
Start Marketing Date : 2024-04-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : EXPORT ONLY
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6206
Start Marketing Date : 2018-01-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-952
Start Marketing Date : 2011-03-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : EXPORT ONLY
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-705
Start Marketing Date : 2019-11-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (90mg/100mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-714
Start Marketing Date : 2016-05-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (90mg/1001)
Marketing Category : EXPORT ONLY
NDC Package Code : 51552-1018
Start Marketing Date : 2022-06-20
End Marketing Date : 2025-12-25
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-1943
Start Marketing Date : 2007-02-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-4575
Start Marketing Date : 1997-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12666-0003
Start Marketing Date : 2009-05-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
21
PharmaCompass offers a list of Methocarbamol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methocarbamol manufacturer or Methocarbamol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methocarbamol manufacturer or Methocarbamol supplier.
PharmaCompass also assists you with knowing the Methocarbamol API Price utilized in the formulation of products. Methocarbamol API Price is not always fixed or binding as the Methocarbamol Price is obtained through a variety of data sources. The Methocarbamol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mioflex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mioflex, including repackagers and relabelers. The FDA regulates Mioflex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mioflex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mioflex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mioflex supplier is an individual or a company that provides Mioflex active pharmaceutical ingredient (API) or Mioflex finished formulations upon request. The Mioflex suppliers may include Mioflex API manufacturers, exporters, distributors and traders.
click here to find a list of Mioflex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mioflex as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Mioflex API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Mioflex as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Mioflex and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mioflex NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Mioflex suppliers with NDC on PharmaCompass.
We have 13 companies offering Mioflex
Get in contact with the supplier of your choice:
